GLPG0634 50mg

GLPG0634 is an orally-available, selective inhibitor of JAK1 (Janus kinase 1) being developed by Galapagos for the treatment of rheumatoid arthritis and potentially other inflammatory diseases.

Price Not Available 50mg GLPG0634 50mg Supplier Page
Trivial name GLPG0634 50mg
Catalog Number A13162-50
Alternative Name(s) N/A
Molecular Formula C23H18N6O2
CAS# 1206101-20-3
SMILES c1cc(n2c(c1)nc(n2)NC(=O)C3CC3)c4ccc(cc4)OCc5ccc(nc5)C#N
Size 50mg
Supplier Page http://www.adooq.com/glpg0634.html